Table 1. Associations between cardiac biomarkers and serious outcomes in an ED population with potential ACS (N = 186).a
BiomarkerSerious 72-h cardiac outcome (n = 24)No serious 72-h cardiac outcome (n = 162)Pb
Age, years (n = 186: 24 + 162)65 (56–73)59 (49–73)0.24
hs-cTnI, ng/L (n = 159: 20 + 139)39 (19–367)6.8 (4.7–12)<0.0001
hs-cTnT, ng/L (n = 178: 22 + 156)43 (14–94)4.6 (<3.0–12)<0.0001
Enhanced AccuTnI, μg/L (n = 172: 20 + 152)0.05 (0.016–0.55)0.005 (0.002–0.12)<0.0001
IL-6, ng/L (n = 163: 20 + 143)3.4 (2.9–4.1)3.7 (1.9–7.3)0.70
NT-proBNP, ng/L (n = 172: 21 + 151)506 (139–3137)123 (38–419)0.004
Abbott AxSym cTnI, μg/L (n = 185: 24 + 161)0.30 (0.30–2.3)0.30 (0.30–0.30)<0.0001
CK-MB, μg/L (n = 171: 23 + 148)4.0 (1.0–8.0)2.0 (1.0–3.0)0.002
IMA,c U/L (n = 173: 23 + 150)84 (80–98)89 (81–94)0.78
Total CK, U/L (n = 186: 24 + 162)103 (74–160)102 (63–155)0.53
  • a Data are presented as the median (interquartile range).

  • b Wilcoxon Mann–Whitney test.

  • c IMA, ischemia-modified albumin.